Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

252 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-16

Study Completion Date

2028-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The prevalence of Metabolic dysfunction-associated steatotic liver disease (MASLD) and its severe form, Metabolic dysfunction-associated steatohepatitis (MASH), is high and they are increasingly becoming major causes of cirrhosis, hepatocellular carcinoma (HCC), and the need for liver transplantation. Due to the lack of noticeable symptoms during the early stages, the detection of MASLD is often delayed until the disease has advanced.

Currently, the treatment options MASLD are limited to lifestyle interventions such as dietary changes and physical activity. Despite the increasing prevalence of MASLD, there are no drugs available on the market specifically for this condition.

The goal is to made new model care which integrates the standard clinical procedures with a digital approach, namely a mobile application for patients and a clinical dashboard for healthcare professionals (HCPs), integrated with simple clinical data (anthropometric, laboratory and imaging data).

This study wants to test the feasibility of integrating a digital intervention to improve the patient engagement and linkage to care in order to identify the advanced MASLD at earliest stage (secondary prevention) and mitigate the impact of ongoing advanced liver disease helping patients to manage the long-term effect of disease.

To achieve this goal the study will leverage on a mobile app named OpenTele in order to test the adherence to lifestyle changes in patient with MASLD and on the connected clinical dashboard.

The app aims at integrating the standard clinical practice with digital technologies able to guide and support patients in order to seamlessly integrate secondary prevention strategies in their everyday life with 2 main aims:

* to implement a strategy for delay progression of liver disease;
* to reduce the effect of cirrhosis (tertiary prevention).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

NCT06888310

NASH NAFLD

RECRUITING NA

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

NCT07280143

Breast Cancer Survivors Colorectal (Colon or Rectal) Cancer Survivors MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

RECRUITING

DIAbetes and NAFLD

NCT06315361

NAFLD Diabetes NASH +3 more

ACTIVE_NOT_RECRUITING

Long Term Prediction of MASH-related HCC Risk by Proteomics

NCT07332611

MASH-related HCC

NOT_YET_RECRUITING

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

NCT06661655

Metabolic Syndrome X Fatty Liver MASH - Metabolic Dysfunction-Associated Steatohepatitis +4 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

NASH NAFLD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with MASLD and LSM\>= 10 kPa
* Age \>= 18 years old
* Sufficient digital literacy or supported from a caregiver with sufficient digital literacy
* Smartphone (Android or iOS) able to download and run the App
* Able to understand and communicate in Italian
* Able to sign the informed consent